Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41.
Journal: Breast cancer research and treatment
Published: November 30, 2022
Comparison of Radiation With or Without Concurrent Trastuzumab for HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy: A Phase III Clinical Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 19, 2021
Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 25, 2019
Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer.
Journal: Journal of the American Geriatrics Society
Published: March 20, 2018
The preference to receive chemotherapy and cancer-related outcomes in older adults with breast cancer CALGB 49907 (Alliance).
Journal: Journal of geriatric oncology
Published: November 07, 2017
Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 13, 2016
Tamoxifen Dose Escalation in Patients With Diminished CYP2D6 Activity Normalizes Endoxifen Concentrations Without Increasing Toxicity.
Journal: The oncologist
Published: November 24, 2015
In vivo assessment of the metabolic activity of CYP2D6 diplotypes and alleles.
Journal: British journal of clinical pharmacology
Published: January 08, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026